Modified peptides, comprising an FC domain, as therapeutic agents

Details for Australian Patent Application No. 2001259432 (hide)

Owner Amgen Inc.

Inventors Gudas, Jean Marie; Boone, Thomas Charles; Cheetham, Janet C.; Liu, Chuan-Fa; Feige, Ulrich

Agent Shelston IP

Pub. Number AU-B-2001259432

PCT Pub. Number WO01/83525

Priority 09563286 03.05.00 US

Filing date 2 May 2001

Wipo publication date 12 November 2001

Acceptance publication date 21 April 2005

International Classifications

C07K 014/00 Peptides having more than 20 amino acids

Event Publications

21 April 2005 Application Accepted

  Published as AU-B-2001259432

18 August 2005 Standard Patent Sealed

27 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001259433-Business-to-employee interactive reward and redemption system and method

2001259431-Oxygen scavenging high barrier polyamide compositions for packaging applications